Glaukos Announces Licensing Agreement with Attillaps Holdings, Inc.
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...
Over the Next Decade, Optimistic Viewpoint of Commercial Aviation’s Growth Out of the Pandemic; Airbus to Extend Lead in Narrowbody...
Vancouver, British Columbia--(Newsfile Corp. - September 20, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"...
This transaction by issuance of Units allows the Company to secure its financing until the end of the third quarter...